Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 17, 2021
As the GFF wraps up its sixth year of operations, enters its next strategic period, and undertakes an important replenishment campaign to raise an additional $2.5 billion in trust fund resources, we are excited to share new work on the role of the GFF in improving the impact of health spending for R...
Blog Post
December 09, 2021
Antibiotic resistance (AMR) is not a new problem. However, the global community has been slow to implement recommended policy measures and achieve systemic change. CGD will launch a working group on antimicrobial resistance—seeking to improve antibiotic access and R&D in low- and middle-inc...
Blog Post
October 26, 2021
Africa’s informal sector remains the largest in the world. According to the International Labor Organization, it claims almost 90 percent of the economy in sub-Saharan Africa and about two-thirds in North Africa (although there is significant heterogeneity in its size across countries).
Blog Post
October 21, 2021
Poor understanding about vaccine capacity was one of the reasons why the world did not have the infrastructure needed to manufacture sufficient doses. This blogs proposes three actions to start tracking manufacturing capacity better and create robust estimates for the world’s vac...
Blog Post
August 30, 2021
Germany has stepped up as an important player in global health in recent years, rising to become the third largest government donor to health in 2019. Notably, Germany has played a key role in WHO reform efforts; it is the largest donor to WHO for the 2020-21 budget period, and one of the largest WH...
Blog Post
August 18, 2021
As the COVID-19 pandemic continues to rage and public funding is increasingly scarce, the need for high-quality, timely evidence on the effectiveness of public programs has never been clearer. In this blog, we share a top-line summary of the methodological and data advances alongside recommenda...